Scientists develop new form of antibiotic to combat multidrug resistant bacteria

          Source: Xinhua| 2018-09-28 12:22:28|Editor: Li Xia
          Video PlayerClose

          SYDNEY, Sept. 28 (Xinhua) -- A new antibiotic, developed by an Australian led-team of scientists, revealed on Friday, could present a solution to the problem of drug resistant bacteria, which is expected to present an ever increasing concern in the coming century.

          The new kind of antibiotic was developed to limit multidrug resistance by targeting and disrupting key elements in bacterial cells, by scientists from Griffith University (GU), in collaboration with colleagues from Queensland University of Technology, the United States' Indiana University and China's Dezhou University.

          "We tried to develop a new type of antibiotics that act differently than what we are using right now," Professor Yaoqi Zhou from GU's Institute for Glycomics told Xinhua.

          "The way most antibiotics stop key functions in bacteria is that they bind to the surface of an essential protein so that it is unable to perform its normal function."

          "Our technique with this new antibiotic approach is different -- instead of binding to the surface of the protein, we disrupt the structure of the protein, which stops it functioning."

          In one test Zhou said, the team saw a 500-fold resistance develop to a commonly used antibiotic over 30 days, where as their newly developed antibiotic encountered no developed resistance at all.

          Additionally the new drug may be useful in cancer treatment, another area where drug resistance is a major hurdle.

          "What we've found in the concept is that it's not only working for antibiotics but should also work for anti-cancer, which also has a lot of problems in terms of drug resistance, also anti-viral - viral infections have a lot of problems with anti-drug resistance," Zhou said.

          "So I think this is a concept that should be useful for any other kinds of disease which also has problems with drug resistance issues."

          Although still in the early theoretical stage, Zhou is hopeful that the method will progress to animal testing and eventually clinical trials, and provide an answer to what is an increasingly urgent international crisis.

          TOP STORIES
          EDITOR’S CHOICE
          MOST VIEWED
          EXPLORE XINHUANET
          010020070750000000000000011100001374987631
          无码人妻一区二区三区四区av_亚洲精品911在线永久观看_精品一区二区国产在线观看_日韩不卡一区二区视频在线

                  亚洲免费在线观看片 | 亚洲国产大片一区官网 | 五月天激情视频在线 | 亚洲一品道在线观看 | 亚洲天啪视频在线 | 日韩视频亚洲视频 |